VENTAIRE Drug Patent Profile
✉ Email this page to a colleague
When do Ventaire patents expire, and when can generic versions of Ventaire launch?
Ventaire is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in VENTAIRE is protokylol hydrochloride. Additional details are available on the protokylol hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VENTAIRE?
- What are the global sales for VENTAIRE?
- What is Average Wholesale Price for VENTAIRE?
Summary for VENTAIRE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Patent Applications: | 814 |
DailyMed Link: | VENTAIRE at DailyMed |
![VENTAIRE drug patent expirations Drug patent expirations by year for VENTAIRE](/p/graph/s/t/VENTAIRE-patent-expirations.png)
US Patents and Regulatory Information for VENTAIRE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | VENTAIRE | protokylol hydrochloride | TABLET;ORAL | 083459-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |